258 related articles for article (PubMed ID: 28240749)
1. Regression in primary cutaneous melanoma: etiopathogenesis and clinical significance.
Aung PP; Nagarajan P; Prieto VG
Lab Invest; 2017 Jun; 97(6):657-668. PubMed ID: 28240749
[TBL] [Abstract][Full Text] [Related]
2. [Regression in malignant melanoma. Definition, etiopathogenesis, morphology and differential diagnosis].
Paredes BE
Pathologe; 2007 Nov; 28(6):453-63. PubMed ID: 17874109
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma.
Clemente CG; Mihm MC; Bufalino R; Zurrida S; Collini P; Cascinelli N
Cancer; 1996 Apr; 77(7):1303-10. PubMed ID: 8608507
[TBL] [Abstract][Full Text] [Related]
4. A clinical histologic, and immunologic study of a case of metastatic malignant melanoma undergoing spontaneous remission.
Bodurtha AJ; Berkelhammer J; Kim YH; Laucius JF; Mastrangelo MJ
Cancer; 1976 Feb; 37(2):735-42. PubMed ID: 943226
[TBL] [Abstract][Full Text] [Related]
5. Primary cutaneous melanoma. Identification of prognostic groups and estimation of individual prognosis for 5093 patients.
Garbe C; Büttner P; Bertz J; Burg G; d'Hoedt B; Drepper H; Guggenmoos-Holzmann I; Lechner W; Lippold A; Orfanos CE
Cancer; 1995 May; 75(10):2484-91. PubMed ID: 7736392
[TBL] [Abstract][Full Text] [Related]
6. Metastatic melanoma to the skin simulating blue nevus.
Busam KJ
Am J Surg Pathol; 1999 Mar; 23(3):276-82. PubMed ID: 10078917
[TBL] [Abstract][Full Text] [Related]
7. Thin Melanoma: A Generic Term Including Four Histological Subtypes of Cutaneous Melanoma.
Roncati L; Pusiol T; Piscioli F
Acta Dermatovenerol Croat; 2016 Dec; 24(4):169-174. PubMed ID: 28128089
[TBL] [Abstract][Full Text] [Related]
8. Interobserver variability on the histopathologic diagnosis of cutaneous melanoma and other pigmented skin lesions.
Corona R; Mele A; Amini M; De Rosa G; Coppola G; Piccardi P; Fucci M; Pasquini P; Faraggiana T
J Clin Oncol; 1996 Apr; 14(4):1218-23. PubMed ID: 8648377
[TBL] [Abstract][Full Text] [Related]
9. Dysplastic melanocytic nevi in histologic association with 234 primary cutaneous melanomas.
Rhodes AR; Harrist TJ; Day CL; Mihm MC; Fitzpatrick TB; Sober AJ
J Am Acad Dermatol; 1983 Oct; 9(4):563-74. PubMed ID: 6630618
[TBL] [Abstract][Full Text] [Related]
10. Reporting regression in primary cutaneous melanoma. Part 1: history, histological criteria and pathogenesis.
Cartron AM; Aldana PC; Khachemoune A
Clin Exp Dermatol; 2021 Jan; 46(1):28-33. PubMed ID: 32597504
[TBL] [Abstract][Full Text] [Related]
11. Quantitative alterations in cutaneous Langerhans cells during the evolution of malignant melanoma of the skin.
Stene MA; Babajanians M; Bhuta S; Cochran AJ
J Invest Dermatol; 1988 Aug; 91(2):125-8. PubMed ID: 3260930
[TBL] [Abstract][Full Text] [Related]
12. Histopathologic diagnosis of dysplastic nevi: concordance among pathologists convened by the World Health Organization Melanoma Programme.
Clemente C; Cochran AJ; Elder DE; Levene A; MacKie RM; Mihm MC; Rilke F; Cascinelli N; Fitzpatrick TB; Sober AJ
Hum Pathol; 1991 Apr; 22(4):313-9. PubMed ID: 1741810
[TBL] [Abstract][Full Text] [Related]
13. Histologic features and sensitivity of diagnosis of clinically unsuspected cutaneous melanoma.
Witheiler DD; Cockerell CJ
Am J Dermatopathol; 1991 Dec; 13(6):551-6. PubMed ID: 1805650
[TBL] [Abstract][Full Text] [Related]
14. Dysplastic melanocytic nevi: a reproducible histologic definition emphasizing cellular morphology.
Rhodes AR; Mihm MC; Weinstock MA
Mod Pathol; 1989 Jul; 2(4):306-19. PubMed ID: 2762287
[TBL] [Abstract][Full Text] [Related]
15. Pathologists' Use of Second Opinions in Interpretation of Melanocytic Cutaneous Lesions: Policies, Practices, and Perceptions.
Geller BM; Frederick PD; Knezevich SR; Lott JP; Nelson HD; Titus LJ; Carney PA; Tosteson ANA; Onega TL; Barnhill RL; Weinstock MA; Elder DE; Piepkorn MW; Elmore JG
Dermatol Surg; 2018 Feb; 44(2):177-185. PubMed ID: 28858936
[TBL] [Abstract][Full Text] [Related]
16. Primary invasive melanoma and basal cell carcinoma (collision tumor) with blue nevus-like cutaneous metastases.
King R; Lyons J; Meyers AL; Googe PB; Page RN; Gupta VK
J Cutan Pathol; 2007 Aug; 34(8):629-33. PubMed ID: 17640233
[TBL] [Abstract][Full Text] [Related]
17. Differentiating regressed melanoma from regressed lichenoid keratosis.
Chan AH; Shulman KJ; Lee BA
J Cutan Pathol; 2017 Apr; 44(4):338-341. PubMed ID: 28026045
[TBL] [Abstract][Full Text] [Related]
18. Association of Histologic Regression With a Favorable Outcome in Patients With Stage 1 and Stage 2 Cutaneous Melanoma.
El Sharouni MA; Aivazian K; Witkamp AJ; Sigurdsson V; van Gils CH; Scolyer RA; Thompson JF; van Diest PJ; Lo SN
JAMA Dermatol; 2021 Feb; 157(2):166-173. PubMed ID: 33355600
[TBL] [Abstract][Full Text] [Related]
19. Structural correlations between dermoscopic features of cutaneous melanomas and histopathology using transverse sections.
Rezze GG; Scramim AP; Neves RI; Landman G
Am J Dermatopathol; 2006 Feb; 28(1):13-20. PubMed ID: 16456319
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological Features and Prognostic Factors of Malignant Melanoma: A Retrospective Analysis of Thai Patients in Ramathibodi Hospital.
Ingkaninanda P; Visessiri Y; Rutnin S
J Med Assoc Thai; 2015 Aug; 98(8):820-7. PubMed ID: 26437541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
